logo

For the Inventor, By the Inventor

Phoenixville, PA, United States of America

James Martin Samanen

This inventor holds 17 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Other. Active years: 1993-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Martin Samanen. Retrieved from https://idiyas.com/inventor/james-martin-samanen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 228(Granted Patents)


Location History:

  • Philadelphia, PA (US) (1993)
  • Phoenixville, PA (US) (1995 - 2003)

Company Filing History:

goldMedal16 out of 2,198 
 
Smithkline Beecham Corporation
 patents
silverMedal1 out of 834,513 
Other
 patents

Years Active: 1993-2003

Loading Chart...
17 patents (USPTO):Explore Patents
1. 6576643 - Vitronectin receptor antagonists (2003-06-10),
2. 6403578 - Bicyclic fibrinogen antagonists (2002-06-11),
3. 6159964 - Vitronectin receptor antagonists (2000-12-12),
4. 6117910 - Bicyclic fibrinogen antagonists (2000-09-12),
5. 6117866 - Bicyclic fibrinogen antagonists (2000-09-12),
6. 6069143 - Fibrinogen receptor antagonists (2000-05-30),
7. 6028087 - Platelet aggregation inhibiting compounds (2000-02-22),
8. 5849690 - Anti-aggregatory peptides (1998-12-15),
9. 5756519 - Fibrinogen receptor antagonists (1998-05-26),
10. 5726192 - Platelet aggregation inhibiting compounds (1998-03-10),
11. 5643872 - Cyclic anti-aggregatory peptides (1997-07-01),
12. 5602145 - Bicyclic fibrinogen antagonists (1997-02-11),
13. 5565480 - Substituted histidines (1996-10-15),
14. 5530017 - Method of antagonizing angiotensin II receptors in mammals using (1996-06-25),
15. 5444081 - Substituted histidines having angiotension II receptor antagonist (1995-08-22),

Title: James Martin Samanen: A Pioneer in Pharmaceutical Innovations

Introduction

James Martin Samanen, an esteemed inventor based in Phoenixville, PA, has made significant contributions to the pharmaceutical industry, holding a remarkable total of 17 patents. His innovative work has paved the way for advancements in medical treatments, particularly in receptor antagonists.

Latest Patents

Among his latest patents, Samanen has developed vitronectin receptor antagonists and bicyclic fibrinogen antagonists. These inventions highlight his dedication to addressing complex medical challenges and improving therapeutic options.

Career Highlights

Throughout his career, Samanen has worked with prominent companies, notably the SmithKline Beecham Corporation. His tenure at this leading pharmaceutical company has undoubtedly influenced his innovative approach and deepened his expertise in drug development.

Collaborations

James Martin Samanen has collaborated with notable coworkers, including William Edward Bondinell and Richard McCulloch Keenan. These professional partnerships have contributed to the success of his projects, showcasing the importance of teamwork in scientific endeavors.

Conclusion

James Martin Samanen stands as a testament to the power of innovation in the field of pharmaceuticals. With a strong portfolio of patents and a history of collaboration with esteemed professionals, he continues to inspire future inventors and researchers in the pursuit of groundbreaking medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…